FAQ/Help |
Calendar |
Search |
Today's Posts |
![]() |
|
ALS News & Research For postings of news or research links and articles related to ALS |
Reply |
|
Thread Tools | Display Modes |
![]() |
#1 | |||
|
||||
Grand Magnate
|
MediciNova Inc. reveals encouraging interim data from Lou Gehrigs trial
MediciNova Inc. (NASDAQ:MNOV) reveals encouraging interim data from Lou Gehrigs trial |
|||
![]() |
![]() |
![]() |
#2 | |||
|
||||
Grand Magnate
|
MediciNova Presents Encouraging Interim Data
MediciNova Presents Encouraging Interim Data - Hot Stock Herald |
|||
![]() |
![]() |
![]() |
#3 | |||
|
||||
Grand Magnate
|
MediciNova Announces Exploratory Interim Clinical Outcomes Data from Clinical Trial of MN-166 (ibudilast) in ALS Presented at the 27th International Symposium on ALS/MND in Dublin, Ireland
MediciNova Announces Exploratory Interim Clinical Outcomes Data from Clinical Trial of MN-166 (ibudilast) in ALS Presented at the 27th International Symposium on ALS/MND in Dublin, Ireland - |
|||
![]() |
![]() |
![]() |
#4 | |||
|
||||
Grand Magnate
|
MediciNova Announces Exploratory Interim Clinical Outcomes Data from Clinical Trial of MN-166 (ibudilast) in ALS Presented at the 27th International Symposium on ALS/MND in Dublin, Ireland
MediciNova Announces Exploratory Interim Clinical Outcomes Data from Clinical Trial of MN-166 (ibudilast) in ALS Presented at the 27th International Symposium on ALS/MND in Dublin, Ireland Nasdaq:MNOV |
|||
![]() |
![]() |
![]() |
#5 | |||
|
||||
Grand Magnate
|
Outcomes data showed ALS patients who discontinued treatment with MediciNova's ibudilast showed declines in muscle strength
Outcomes data showed ALS patients who discontinued treatment with MediciNova's ibudilast showed declines in muscle strength - MediciNova, Inc. (NASDAQ:MNOV) | Seeking Alpha |
|||
![]() |
![]() |
Reply |
|
|
![]() |
||||
Thread | Forum | |||
AB Science Reports Positive Interim Results in Phase 3 Trial of Masitinib as an ALS | ALS News & Research |